Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 88

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Beta-1 and Not Beta-3 Adrenergic Receptors May Be the Primary Regulator of Human Brown Adipocyte Metabolism

Riis-Vestergaard, Mette Ji, Richelsen, Bjørn, Bruun, Jens Meldgaard, Li, Wei, Hansen, Jacob B, Pedersen, Steen Bønløkke·2020·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/clinem/dgz298
Open this paper in CoChat — free account

Abstract

Purpose: Brown adipose tissue (BAT) activation in humans has gained interest as a potential target for treatment of obesity and insulin resistance. In rodents, BAT is primarily induced through beta-3 adrenergic receptor (ADRB3) stimulation, whereas the primary beta adrenergic receptors (ADRBs) involved in human BAT activation are debated. We evaluated the importance of different ADRB subtypes for uncoupling protein 1 (UCP1) induction in human brown adipocytes. Methods: A human BAT cell model (TERT-hBA) was investigated for subtype-specific ADRB agonists and receptor knockdown on UCP1 mRNA levels and lipolysis (glycerol release). In addition, fresh human BAT biopsies and TERT-hBA were evaluated for expression of ADRB1, ADRB2, and ADRB3 using RT-qPCR. Results: The predominant ADRB subtype in TERT-hBA adipocytes and BAT biopsies was ADRB1. In TERT-hBA, UCP1 mRNA expression was stimulated 11.0-fold by dibutyryl cAMP (dbcAMP), 8.0-fold to 8.4-fold by isoproterenol (ISO; a pan-ADRB agonist), and 6.1-fold to 12.7-fold by dobutamine (ADRB1 agonist), whereas neither procaterol (ADRB2 agonist), CL314.432, or Mirabegron (ADRB3 agonists) affected UCP1. Similarly, dbcAMP, ISO, and dobutamine stimulated glycerol release, whereas lipolysis was unaffected by ADRB2 and ADRB3 agonists. Selective knockdown of ADRB1 significantly attenuated ISO-induced UCP1 expression. Conclusion: The adrenergic stimulation of UCP1 and lipolysis may mainly be mediated through ADRB1. Moreover, ADRB1 is the predominant ADRB in both TERT-hBA and human BAT biopsies. Thus, UCP1 expression in human BAT may, unlike in rodents, primarily be regulated by ADRB1. These findings may have implications for ADRB agonists as future therapeutic compounds for human BAT activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgz298

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 55

  1. Cypess, 2009, Identification and importance of brown adipose tissue in adult humans, N Engl J Med., 360, 1509, 10.1056/NEJMoa0810780 · DOI · Paper page
  2. Poher, 2015, Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance, Front Physiol., 6, 4, 10.3389/fphys.2015.00004 · DOI
  3. Lee, 2016, Brown adipose tissue exhibits a glucose-responsive thermogenic biorhythm in humans, Cell Metab., 23, 602, 10.1016/j.cmet.2016.02.007 · DOI
  4. Klein, 1999, Beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes, J Biol Chem., 274, 34795, 10.1074/jbc.274.49.34795 · DOI
  5. Zennaro, 1998, Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action, J Clin Invest., 101, 1254, 10.1172/JCI1915 · DOI
  6. Ross, 1992, Hibernoma formation in transgenic mice and isolation of a brown adipocyte cell line expressing the uncoupling protein gene, Proc Natl Acad Sci U S A., 89, 7561, 10.1073/pnas.89.16.7561 · DOI
  7. Shinoda, 2015, Genetic and functional characterization of clonally derived adult human brown adipocytes, Nat Med., 21, 389, 10.1038/nm.3819 · DOI · Paper page
  8. Xue, 2015, Clonal analyses and gene profiling identify genetic biomarkers of the thermogenic potential of human brown and white preadipocytes, Nat Med., 21, 760, 10.1038/nm.3881 · DOI · Paper page
  9. Markussen, 2017, Characterization of immortalized human brown and white pre-adipocyte cell models from a single donor, Plos One., 12, e0185624, 10.1371/journal.pone.0185624 · DOI
  10. Warner, 2016, Activation of β3-adrenoceptors increases in vivo free fatty acid uptake and utilization in brown but not white fat depots in high-fat-fed rats, Am J Physiol Endocrinol Metab., 311, E901, 10.1152/ajpendo.00204.2016 · DOI
  11. Meyers, 1997, Beta 3-adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys, J Clin Endocrinol Metab., 82, 395
  12. Yamakawa, 1994, Effect of the adrenergic beta 3-agonist, BRL37344, on heat production by brown adipocytes in obese and in older rats, Tokai J Exp Clin Med., 19, 139
  13. Nedergaard, 2010, The changed metabolic world with human brown adipose tissue: therapeutic visions, Cell Metab., 11, 268, 10.1016/j.cmet.2010.03.007 · DOI · Paper page
  14. Connacher, 1992, Clinical studies with the beta-adrenoceptor agonist BRL 26830A, Am J Clin Nutr., 55, 258S, 10.1093/ajcn/55.1.258s · DOI
  15. Connacher, 1988, Weight loss in obese subjects on a restricted diet given BRL 26830A, a new atypical beta adrenoceptor agonist, Br Med J (Clin Res Ed)., 296, 1217, 10.1136/bmj.296.6631.1217 · DOI
  16. Buemann, 2000, Effects of the two beta3-agonists, ZD7114 and ZD2079 on 24 hour energy expenditure and respiratory quotient in obese subjects, Int J Obes Relat Metab Disord., 24, 1553, 10.1038/sj.ijo.0801452 · DOI
  17. Jéquier, 1992, Thermogenic effects of various beta-adrenoceptor agonists in humans: their potential usefulness in the treatment of obesity, Am J Clin Nutr, 55, 249S, 10.1093/ajcn/55.1.249s · DOI
  18. Connacher, 1990, Tremor and the anti-obesity drug BRL 26830A, Br J Clin Pharmacol., 30, 613, 10.1111/j.1365-2125.1990.tb03821.x · DOI
  19. Cypess, 2015, Activation of human brown adipose tissue by a β3-adrenergic receptor agonist, Cell Metab., 21, 33, 10.1016/j.cmet.2014.12.009 · DOI · Paper page
  20. Baskin, 2018, Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a β3-adrenergic receptor agonist, Diabetes., 67, 2113, 10.2337/db18-0462 · DOI · Paper page
  21. Dehvari, 2018, Mirabegron: potential off target effects and uses beyond the bladder, Br J Pharmacol., 175, 4072, 10.1111/bph.14121 · DOI
  22. Arch, 2011, Challenges in β(3)-adrenoceptor agonist drug development, Ther Adv Endocrinol Metab., 2, 59, 10.1177/2042018811398517 · DOI
  23. Loh, 2019, Acute metabolic and cardiovascular effects of mirabegron in healthy individuals, Diabetes Obes Metab., 21, 276, 10.1111/dom.13516 · DOI
  24. Breining, 2017, High expression of organic cation transporter 3 in human BAT-like adipocytes. Implications for extraneuronal norepinephrine uptake, Mol Cell Endocrinol., 443, 15, 10.1016/j.mce.2016.12.024 · DOI
  25. Patel, 2005, Neck dissection: past, present, future, Surg Oncol Clin N Am., 14, 461, 10.1016/j.soc.2005.04.003 · DOI
  26. Nøhr, 2016, LPS-enhanced glucose-stimulated insulin secretion is normalized by resveratrol, Plos One., 11, e0146840, 10.1371/journal.pone.0146840 · DOI
  27. Arvidsson, 2008, QuantPrime–a flexible tool for reliable high-throughput primer design for quantitative PCR, BMC Bioinformatics., 9, 465, 10.1186/1471-2105-9-465 · DOI
  28. Kuusela, 1997, Adrenergic stimulation of lipoprotein lipase gene expression in rat brown adipocytes differentiated in culture: mediation via beta3- and alpha1-adrenergic receptors, Biochem J., 321, 759, 10.1042/bj3210759 · DOI
  29. Bronnikov, 1999, Beta1 to beta3 switch in control of cyclic adenosine monophosphate during brown adipocyte development explains distinct beta-adrenoceptor subtype mediation of proliferation and differentiation, Endocrinol., 140, 4185, 10.1210/endo.140.9.6972 · DOI
  30. Preitner, 1998, Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new beta-adrenergic receptor in brown adipose tissue, Br J Pharmacol., 124, 1684, 10.1038/sj.bjp.0702007 · DOI
  31. Luo, 2016, Cold-Induced browning dynamically alters the expression profiles of inflammatory adipokines with tissue specificity in mice, Int J Mol Sci, 17, 10.3390/ijms17050795 · DOI
  32. Miller, 2015, Isoproterenol increases uncoupling, glycolysis, and markers of beiging in mature 3T3-L1 adipocytes, Plos One., 10, e0138344, 10.1371/journal.pone.0138344 · DOI
  33. Nohr, 2017, Inflammation downregulates UCP1 expression in brown adipocytes potentially via SIRT1 and DBC1 interaction, Int J Mol Sci, 18, 10.3390/ijms18051006 · DOI
  34. Isidor, 2016, An siRNA-based method for efficient silencing of gene expression in mature brown adipocytes, Adipocyte., 5, 175, 10.1080/21623945.2015.1111972 · DOI
  35. Ma, 1986, Uptake of glucose and release of fatty acids and glycerol by rat brown adipose tissue in vivo, Can J Physiol Pharmacol., 64, 609, 10.1139/y86-101 · DOI
  36. Evans, 2019, Adrenoceptors in white, brown, and brite adipocytes, Br J Pharmacol., 176, 2416, 10.1111/bph.14631 · DOI
  37. Weir, 2018, Substantial metabolic activity of human brown adipose tissue during warm conditions and cold-induced lipolysis of local triglycerides, Cell Metab., 27, 1348, 10.1016/j.cmet.2018.04.020 · DOI · Paper page
  38. Chaudhry, 1999, Differential regulation of functional responses by beta-adrenergic receptor subtypes in brown adipocytes, Am J Physiol., 277, R147
  39. Warner, 2016, Activation of beta3-adrenoceptors increases in vivo free fatty acid uptake and utilization in brown but not white fat depots in high-fat fed rats, Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00204.2016 · DOI
  40. Berkowitz, 1995, Distribution of beta 3-adrenoceptor mRNA in human tissues, Eur J Pharmacol., 289, 223, 10.1016/0922-4106(95)90098-5 · DOI
  41. Deng, 1996, Respective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues, Br J Pharmacol., 118, 929, 10.1111/j.1476-5381.1996.tb15488.x · DOI
  42. Chondronikola, 2016, Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans, Cell Metab., 23, 1200, 10.1016/j.cmet.2016.04.029 · DOI
  43. Ding, 2018, De novo reconstruction of human adipose transcriptome reveals conserved lncRNAs as regulators of brown adipogenesis, Nat Commun., 9, 1329, 10.1038/s41467-018-03754-3 · DOI
  44. Pisani, 2011, Differentiation of human adipose-derived stem cells into “Brite” (Brown-in-White) Adipocytes, Front Endocrinol., 2, 87, 10.3389/fendo.2011.00087 · DOI
  45. Wabitsch, 2001, Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation, Int J Obes Relat Metab Disord., 25, 8, 10.1038/sj.ijo.0801520 · DOI
  46. Zilberfarb, 1997, Human immortalized brown adipocytes express functional beta3-adrenoceptor coupled to lipolysis, J Cell Sci., 110, 801, 10.1242/jcs.110.7.801 · DOI
  47. Mattsson, 2011, β 1-Adrenergic receptors increase UCP1 in human MADS brown adipocytes and rescue cold-acclimated β 3-adrenergic receptor-knockout mice via nonshivering thermogenesis, Am J Physiol Endocrinol Metab., 301, E1108, 10.1152/ajpendo.00085.2011 · DOI
  48. Guennoun, 2015, Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype, J Transl Med., 13, 135-015-0480-0486, 10.1186/s12967-015-0480-6 · DOI
  49. Granneman, 1991, Molecular cloning and expression of the rat beta 3-adrenergic receptor, Mol Pharmacol, 40, 895
  50. Nahmias, 1991, Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes, EMBO J, 10, 3721, 10.1002/j.1460-2075.1991.tb04940.x · DOI · Paper page
  51. Malik, 2012, Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study, Clin Pharmacol Ther, 92, 696, 10.1038/clpt.2012.181 · DOI
  52. Finlin, 2018, Human adipose beiging in response to cold and mirabegron, JCI Insight, 3, 10.1172/jci.insight.121510 · DOI · Paper page
  53. Redman, 2007, Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study, J Clin Endocrinol Metab, 92, 527, 10.1210/jc.2006-1740 · DOI · Paper page
  54. Yen, 1995, Beta-agonists as antiobesity, antidiabetic and nutrient partitioning agents, Obes Res, 3, 531S, 10.1002/j.1550-8528.1995.tb00223.x · DOI
  55. Baker, 2010, The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors, Br J Pharmacol, 160, 1048, 10.1111/j.1476-5381.2010.00754.x · DOI · Paper page

Cited by

See all 88

Metadata

Authors
Riis-Vestergaard, M. J., Richelsen, B., Bruun, J. M., Li, W., Hansen, J. B., & Pedersen, S. B.
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2019-12-26
Volume
105
Issue
4
Pages
e994-e1005
ISSN
  • 0021-972X
  • 1945-7197
DOI
10.1210/clinem/dgz298
Cited by
88
References
5
Language
en
Licence
academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Funders
  • Innovation Fund Denmark
  • A.P. Moeller Foundation
  • Faculty of Health, Aarhus University

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Beta-1 and Not Beta-3 Adrenergic Receptors May Be the Primary Regulator of Human Brown Adipocyte Metabolism. https://app.cochat.ai/papers/10.1210/clinem/dgz298
The paper
Riis-Vestergaard, M. J., Richelsen, B., Bruun, J. M., Li, W., Hansen, J. B., & Pedersen, S. B. (2020). Beta-1 and Not Beta-3 Adrenergic Receptors May Be the Primary Regulator of Human Brown Adipocyte Metabolism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgz298

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.